EMPAGLIFLOZIN IMPROVES VASCULAR REGENERATIVE CELL CONTENT IN PEOPLE WITHOUT DIABETES
Ehab Bakbak(The University of Queensland), David A. Hess(Western University), Catharine Wang(Boston University), A. Krishnaraj(Toronto Public Health), P. Puar(Toronto Public Health), C. David Mazer(St. Michael's Hospital), Hwee Teoh(St. Michael's Hospital), Kim A. Connelly(St. Michael's Hospital), R. Verma(Toronto Public Health), Sumit Verma(Emory University), Daniella C. Terenzi(St. Michael's Hospital), Tamique Mason(Toronto Public Health), Ori D. Rotstein(St. Michael's Hospital), Adrian Quan(St. Michael's Hospital), Andrew T. Yan(St. Michael's Hospital)
Cited by 0
Related Papers
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711
Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Repair
|Journal of the American College of Cardiology|2022|261
Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies
|Stem Cells|2017|205
Interrelationship of preoperative anemia, intraoperative anemia, and red blood cell transfusion as potentially modifiable risk factors for acute kidney injury in cardiac surgery: a historical multicentre cohort study
|Canadian Journal of Anesthesia/Journal canadien d anesthésie|2014|168
High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy
|Cardiovascular Diabetology|2014|130